A GSH and β-Galactosidase Sequential-Activated Dual-Locked Fluorescent Nanoprobe for Precise Liver Cancer Diagnosis and Intraoperative Navigation
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c02961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Yu Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan…. Hauptthemen laut MEDLINE: Glutathione, beta-Galactosidase, Fluorescent Dyes, Liver Neoplasms. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Wuhan Young Talents Plan, Natural Science Foundation of Wuhan Exploration Project-Key Project for Clinical Research, Wuhan Children?s Hospital Translational Medicine Project.
Abstract (Originalsprache)
Accurate intraoperative navigation for solid tumors is often hindered by the nonspecific activation of imaging probes in non-target tissues. In this work, a near-infrared dual-locked fluorescent nanoprobe HCy-M@MSN@PEG was developed that can be sequentially activated by glutathione (GSH) and β-galactosidase (β-Gal), enabling highly specific imaging of liver tumors. This nanoprobe is constructed by encapsulating a β-Gal-responsive small-molecule probe (HCy-M) within PEGylated mesoporous silica nanoparticles (MSN@PEG). Upon exposure to the first biomarker GSH, the nanoprobe undergoes rapid disassembly, releasing the encapsulated HCy-M, which then responds to the second biomarker β-Gal, producing a fluorescence turn-on signal that enables selective imaging of liver tumors. Through meticulous material optimization, including the incorporation of disulfide bonds into both the MSNs framework and surface PEG chains to accelerate GSH responsiveness, as well as the modification of the structure of small-molecule probe to balance loading efficiency and release rate, the nanoprobe achieved a release efficiency of 42.9% within 3 h under GSH stimulation, and the released HCy-M responded to β-Gal within 20 min with a 10.25-fold fluorescence enhancement. The probe efficiently discriminated between normal, senescent, and liver cancer cells. In vivo, it exhibited excellent tumor targeting with a signal-to-background ratio of 4.47 and successfully guided precise resection of liver tumors via fluorescence imaging in mouse models. This work provides a promising tool for precise liver cancer diagnosis and intraoperative navigation, with potential for advancing fluorescence-based theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Green Chemical Process of Ministry of Education, School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan430205, China.
- Department of Pharmacy, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science &Technology, Wuhan430016, China.
ORCID-Profile: Dugang Chen, Gang Nie
Förderung
- Wuhan Young Talents Plan
- Natural Science Foundation of Wuhan Exploration Project-Key Project for Clinical Research
- Wuhan Children?s Hospital Translational Medicine Project
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Gao, Y., Fan, S., Liu, Y., Peng, Y., Chen, D., Liu, M., & Nie, G. (2026). A GSH and β-Galactosidase Sequential-Activated Dual-Locked Fluorescent Nanoprobe for Precise Liver Cancer Diagnosis and Intraoperative Navigation. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02961
Vancouver
Gao Y, Fan S, Liu Y, Peng Y, Chen D, Liu M, et al. A GSH and β-Galactosidase Sequential-Activated Dual-Locked Fluorescent Nanoprobe for Precise Liver Cancer Diagnosis and Intraoperative Navigation. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02961
BibTeX
@article{Gao2026,
author = {Gao, Yu and Fan, Sijun and Liu, Yinuo and Peng, Yanlin and Chen, Dugang and Liu, Maochang and Nie, Gang},
title = {A GSH and β-Galactosidase Sequential-Activated Dual-Locked Fluorescent Nanoprobe for Precise Liver Cancer Diagnosis and Intraoperative Navigation},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c02961}
}
EUVIMED